Iovance Biotherapeutics (IOVA) Current Ratio: History & Chart

Iovance Biotherapeutics, Inc.(IOVA)

Biotechnology · San Carlos, CA

$13.18-0.97 (-6.85%)

Delayed quote: Oct 6, 2026, 12:45 PM EDT

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recurrent, metastatic, or persistent. Additionally, investigational product LN-145 is undergoing evaluation in trial C-145-03 for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. maintains strategic alliances and licensing arrangements with several distinguished entities, including H. Lee Moffitt Cancer Center, M.D. Anderson Cancer Center, Ohio State University, the Centre hospitalier de l'Université de Montreal, Cellectis S.A., and Novartis Pharma AG. Established in 2007, the company was previously known as Lion Biotechnologies, Inc. It adopted its current name, Iovance Biotherapeutics, Inc., in June 2017. Its corporate offices are located in San Carlos, California.

San Carlos, CA

975 employees

www.iovance.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Frederick G. Vogt

View full financials

IOVA Current Ratio Metrics

CURRENT RATIO

4.35

CURRENT RATIO AVG TTM

3.57

CURRENT RATIO AVG 3Y

3.83

CURRENT RATIO AVG 5Y

4.52

CURRENT RATIO AVG 10Y

9.35

CURRENT RATIO AVG 15Y

9.18

CURRENT RATIO AVG 20Y

8.29

CURRENT VS TTM AVG

+21.83%

CURRENT VS 3Y AVG

+13.31%

CURRENT VS 5Y AVG

-3.82%

CURRENT VS 10Y AVG

-53.51%

CURRENT VS 15Y AVG

-52.65%

CURRENT VS 20Y AVG

-47.62%

SECTOR MEDIAN · HEALTHCARE

3.58

median of 778 covered companies

CURRENT VS SECTOR MEDIAN

+21.37%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Iovance Biotherapeutics, Inc. (IOVA)	$5.88B	4.35	3.57	3.83	4.52
Ligand Pharmaceuticals Incorporated (LGND)vs ›	$5.91B	31.18	15.58	12.00	10.69
GRAIL Inc. (GRAL)vs ›	$6.02B	10.95	11.32	6.44	5.89
Kiniksa Pharmaceuticals International, plc (KNSA)vs ›	$5.73B	3.90	3.54	4.15	5.24
CG Oncology Inc. (CGON)vs ›	$5.68B	22.22	29.96	20.77	18.57
RadNet, Inc. (RDNT)vs ›	$5.54B	1.48	1.94	1.50	1.26
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.51B	1.81	1.62	1.66	1.66
Rhythm Pharmaceuticals, Inc. (RYTM)vs ›	$6.28B	3.45	3.83	5.53	6.55
Doximity, Inc. (DOCS)vs ›	$5.33B	6.08	6.53	6.56	6.07
PTC Therapeutics, Inc. (PTCT)vs ›	$5.30B	3.39	2.35	2.11	2.46

NAME

MARKET CAP

CURRENT RATIO

TTM

Iovance Biotherapeutics, Inc. (IOVA)

$5.88B

4.35

3.57

3.83

4.52

Ligand Pharmaceuticals Incorporated (LGND)vs ›

$5.91B

31.18

15.58

12.00

10.69

GRAIL Inc. (GRAL)vs ›

$6.02B

10.95

11.32

6.44

5.89

Kiniksa Pharmaceuticals International, plc (KNSA)vs ›

$5.73B

3.90

3.54

4.15

5.24

CG Oncology Inc. (CGON)vs ›

$5.68B

22.22

29.96

20.77

18.57

RadNet, Inc. (RDNT)vs ›

$5.54B

1.48

1.94

1.50

1.26

MiniMed Group, Inc. Common Stock (MMED)vs ›

$5.51B

1.81

1.62

1.66

Rhythm Pharmaceuticals, Inc. (RYTM)vs ›

$6.28B

3.45

3.83

5.53

6.55

Doximity, Inc. (DOCS)vs ›

$5.33B

6.08

6.53

6.56

6.07

PTC Therapeutics, Inc. (PTCT)vs ›

$5.30B

3.39

2.35

2.11

2.46

Current Ratio FAQ

What is the current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The current ratio for IOVA stock is 4.35.

Is Iovance Biotherapeutics, Inc.'s current ratio high or low?

The current ratio of 4.35 is in line with its 5-year average of 4.52, near the low end of its 5-year range (2.79–11.01).

What is the TTM average current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The TTM average current ratio for IOVA stock is 3.57.

What is the 3Y average current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The 3Y average current ratio for IOVA stock is 3.83.

What is the 5Y average current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The 5Y average current ratio for IOVA stock is 4.52.

What is the 10Y average current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The 10Y average current ratio for IOVA stock is 9.35.

What is the 15Y average current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The 15Y average current ratio for IOVA stock is 9.18.

What is the 20Y average current ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The 20Y average current ratio for IOVA stock is 8.29.

DATE	CURRENT RATIO
2026-06-30	4.35
2026-03-31	3.60
2025-12-31	3.20
2025-09-30	3.41
2025-06-30	3.27
2025-03-31	4.18
2024-12-31	3.74
2024-09-30	4.22
2024-06-30	5.15
2024-03-31	4.63
2023-12-31	2.79
2023-09-30	4.21
2023-06-30	3.10
2023-03-31	7.31
2022-12-31	5.24
2022-09-30	4.67
2022-06-30	6.72
2022-03-31	6.36
2021-12-31	5.69
2021-09-30	9.00
2021-06-30	11.01
2021-03-31	10.99
2020-12-31	11.59
2020-09-30	11.24
2020-06-30	14.25
2020-03-31	6.48
2019-12-31	8.10
2019-09-30	10.61
2019-06-30	12.14
2019-03-31	20.09
2018-12-31	33.02
2018-09-30	15.94
2018-06-30	19.73
2018-03-31	20.61
2017-12-31	15.09
2017-09-30	20.09
2017-06-30	15.29
2017-03-31	27.73
2016-12-31	34.12
2016-09-30	56.53
2016-06-30	41.76
2016-03-31	54.29
2015-12-31	63.79
2015-09-30	38.67
2015-06-30	60.40
2015-03-31	58.31
2014-12-31	27.06
2014-09-30	13.69
2014-06-30	16.01
2014-03-31	16.28
2013-12-31	8.74
2013-09-30	0.04
2013-06-30	0.17
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00
2011-12-31	0.04
2011-09-30	0.36
2011-06-30	0.17
2011-03-31	1.02
2010-12-31	1.58
2010-09-30	1.40
2010-06-30	13.59
2010-03-31	9.00
2009-12-31	0.36
2009-09-30	0.07
2009-06-30	0.13
2009-03-31	0.21
2008-12-31	0.92
2008-09-30	5.33
2008-06-30	8.86
2008-03-31	17.72

DATE

CURRENT RATIO

2026-06-30

4.35

2026-03-31

3.60

2025-12-31

3.20

2025-09-30

3.41

2025-06-30

3.27

2025-03-31

4.18

2024-12-31

3.74

2024-09-30

4.22

2024-06-30

5.15

2024-03-31

4.63

2023-12-31

2.79

2023-09-30

4.21

2023-06-30

3.10

2023-03-31

7.31

2022-12-31

5.24

2022-09-30

4.67

2022-06-30

6.72

2022-03-31

6.36

2021-12-31

5.69

2021-09-30

9.00

2021-06-30

11.01

2021-03-31

10.99

2020-12-31

11.59

2020-09-30

11.24

2020-06-30

14.25

2020-03-31

6.48

2019-12-31

8.10

2019-09-30

10.61

2019-06-30

12.14

2019-03-31

20.09

2018-12-31

33.02

2018-09-30

15.94

2018-06-30

19.73

2018-03-31

20.61

2017-12-31

15.09

2017-09-30

20.09

2017-06-30

15.29

2017-03-31

27.73

2016-12-31

34.12

2016-09-30

56.53

2016-06-30

41.76

2016-03-31

54.29

2015-12-31

63.79

2015-09-30

38.67

2015-06-30

60.40

2015-03-31

58.31

2014-12-31

27.06

2014-09-30

13.69

2014-06-30

16.01

2014-03-31

16.28

2013-12-31

8.74

2013-09-30

0.04

2013-06-30

0.17

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

2011-12-31

0.04

2011-09-30

0.36

2011-06-30

0.17

2011-03-31

1.02

2010-12-31

1.58

2010-09-30

1.40

2010-06-30

13.59

2010-03-31

9.00

2009-12-31

0.36

2009-09-30

0.07

2009-06-30

0.13

2009-03-31

0.21

2008-12-31

0.92

2008-09-30

5.33

2008-06-30

8.86

2008-03-31

17.72

Current Ratio: 4.35

IOVA Current Ratio

IOVA Average Current Ratio Chart

IOVA Current vs Average Current Ratio Chart

IOVA Current Ratio Metrics

IOVA Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

IOVA Current Ratio History

Related Metrics